At a glance
- Originator Mitsubishi Chemical
- Class Anti-ischaemics; Antiplatelets; Prostaglandins; Small molecules
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Thrombosis
Most Recent Events
- 07 Jan 1997 Discontinued-Preclinical for Ischaemic heart disorders in Japan (Unknown route)
- 07 Jan 1997 Discontinued-Preclinical for Thrombosis in Japan (Unknown route)